BBT is one of the recognised partners for the development and manufacture of Antibody Drug Conjugates (ADCs).

The unique possibility to develop and produce ADCs and their components ( toxin/carrier, conjugate) at our partnering manufacturing sites brings great advantages in terms of speed and quality of the drug.

Process development and production of toxins and linkers with a partner is truly a "one-stop-shop" solution to improve drug effectiveness without compromise.

We can follow the development and production of your toxins, and linkers from early development through to commercial supply.